Clinical Trials Browser

INDUSTRY × saracatinib × Clear all

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Phase 2 Completed

139 enrolled 23 charts

BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT00610714 2012-12-18

OVERT-1

Phase 2 Completed

211 enrolled 12 charts

Neoplasms, Ovarian Neoplasms

NCT00704366 2011-05-16

AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00496028 2010-09-22

Phase I Study in Patients With Solid Tumours

Phase 1 Completed

Neoplasms

NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Phase 1 Completed

BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT01000896 2010-02-04

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Phase 1 Withdrawn

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Neoplasms